Literature DB >> 26955243

Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children.

Ji-Hyun Seo1, Chun Woo Lim1, Ji Sook Park1, Jung Sook Yeom1, Jae-Young Lim1, Jin-Su Jun1, Hyang-Ok Woo1, Hee-Shang Youn1, Seung-Chul Baik2, Woo-Kon Lee2, Myung-Je Cho2, Kwang-Ho Rhee2.   

Abstract

We tested correlations between anti-Helicobacter pylori IgG and IgA levels and the urease test, anti-CagA protein antibody, degree of gastritis, and age. In total, 509 children (0-15 years) were enrolled. Subjects were stratified as 0-4 years (n = 132), 5-9 years (n = 274), and 10-15 years (n = 103) and subjected to the urease test, histopathology, ELISA, and western blot using whole-cell lysates of H. pylori strain 51. The positivity rate in the urease test (P = 0.003), the degree of chronic gastritis (P = 0.021), and H. pylori infiltration (P < 0.001) increased with age. The median titer for anti-H. pylori IgG was 732.5 IU/mL at 0-4 years, 689.0 IU/mL at 5-9 years, and 966.0 IU/mL at 10-15 years (P < 0.001); the median titer for anti-H. pylori IgA was 61.0 IU/mL at 0-4 years, 63.5 IU/mL at 5-9 years, and 75.0 IU/mL at 10-15 years (P < 0.001). The CagA-positivity rate was 26.5% at 0-4 years, 36.5% at 5-9 years, and 46.6% at 10-15 years for IgG (P = 0.036), and 11.3% at 0-4 years, 18.6% at 5-9 years, and 23.3% at 10-15 years for IgA (P < 0.001). Anti-H. pylori IgG and IgA titers increased with the urease test grade, chronic gastritis degree, active gastritis, and H. pylori infiltration. Presence of CagA-positivity is well correlated with a high urease test grade and high anti-H. pylori IgG/IgA levels.

Entities:  

Keywords:  Antibodies IgG/IgA; CagA Protein; Children; Helicobacter pylori; Urease

Mesh:

Substances:

Year:  2016        PMID: 26955243      PMCID: PMC4779867          DOI: 10.3346/jkms.2016.31.3.417

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


INTRODUCTION

Helicobacter pylori is an important etiological factor for acute and chronic gastritis, gastric and duodenal ulcers, and gastric adenocarcinoma (1). The severity of H. pylori infection depends on the strain virulence, host susceptibility, and environmental factors (2). The measurement of specific antibodies in serum has been used as a noninvasive method for detecting H. pylori infection (3) and over 90% of H. pylori-infected patients have detectable serum IgG antibodies (4). Serological tests are commercially available, which are easy to perform and inexpensive, but studies on children indicate a high sensitivity range of 50%–90% and the specificity ranges from 83% to 100% (5678). The number of immunoreactive bands significantly increases with age and reactions to the VacA and CagA antigens are more frequently found in older children (9). In our previous study, we found that more than 80% of the seropositive enzyme-linked immunosorbent assay (ELISA) results were CagA positive, whereas the other 20% of the seropositive results using ELISA could be attributed to its reaction with another H. pylori antigen (10). Therefore, the use of whole-cell lysates of H. pylori strain 51 in ELISA may increase the yield when detecting anti-H. pylori antibodies in the Korean population. Several studies have investigated the relationship between antibody titers and the pathogenesis of H. pylori, but the results are inconclusive (311). Quantitative evaluations of anti-H. pylori antibodies or against H. pylori recombinant purified proteins have been performed in some human diseases where H. pylori infections may play a role in their pathogenesis (9121314). However, the clinical significance of high antibody levels to H. pylori according to quantitative ELISA has not been established and high anti-H. pylori antibody levels have not been demonstrated to be predictive of the severity of gastroduodenal diseases or the density of H. pylori colonization. Thus, to help identify factors that correlate with antibody levels in children, we evaluated the correlations between the levels of anti-H. pylori IgG and IgA antibodies and the urease test grade, presence of CagA antigen, degree of gastritis, and age.

MATERIALS AND METHODS

Study population

As a member of the National Biobank of Korea, Gyeongsang National University Hospital (GNUH) collects serum samples from random patients and stores them at −80℃. Among the samples collected over 21 years, we examined those from 509 children who underwent upper gastroduodenoscopy at GNUH during 1991–2010. Thus, we enrolled 509 children and we reviewed the results of urease test and the histopathological findings, and tested the reserved serum. The sera were stratified into three age groups: 0–4 years (n = 132), 5–9 years (n = 274), and 10–15 years (n = 103) (Table 1).
Table 1

Baseline and clinical characteristics

CharacteristicsNo. (%) of children by age groupsP value
0-4 yr5-9 yr10-15 yr
Number1322741030.509
Sex0.999
 Female60 (45.5)125 (45.6)47 (45.6)
 Male72 (54.5)149 (54.4)56 (54.4)
Histopathological findings0.021
 Chronic gastritis
  Normal4 (3.0)4 (1.4)0 (0)
  Mild94 (71.2)211 (77.0)64 (62.1)
  Moderate28 (21.2)46 (16.8)28 (27.2)
  Severe6 (4.5)13 (4.7)11 (10.7)
 Active gastritis0.064
  Normal103 (78.0)214 (78.1)65 (63.1)
  Mild20 (15.2)44 (16.1)27 (26.2)
  Moderate9 (6.8)13 (4.7)9 (8.7)
  Severe0 (0)3 (1.1)2 (1.9)
H. pylori infiltration< 0.001
  Normal98 (74.2)216 (78.8)62 (60.2)
  Mild29 (22.0)46 (16.8)28 (27.2)
  Moderate2 (1.5)11 (4.0)12 (11.7)
  Severe3 (2.3)1 (0.4)1 (1.0)
Urease test0.003
 Negative83 (62.9)170 (62.0)62 (60.2)
 6-24 hr21 (15.9)49 (17.9)5 (4.9)
 < 6 hr28 (21.2)55 (20.1)36 (35.0)

Urease tests and histopathological findings

Three gastric endoscopic biopsies taken from the gastric prepyloric antrum with an Olympus GIF-XP endoscope with pediatric forceps were first subjected to urease tests, which were performed in the endoscopy room. Based on the rapidity of the color change, the subjects were designated as grades 0 (negative, no color change), 1 (color change between 6 and 24 hours), or 2 (color change within 6 hours). Three biopsy specimens each from the gastric antrum and gastric body were stained with hematoxylin-eosin for the histological analyses. The histology results were interpreted according to the Updated Sydney System. All of the histopathological slides that we reviewed had been prepared and donated by the GNUH.

ELISA and western blot analysis

Anti-H.pylori IgG and IgA titers were measured by ELISA (10) using the coated with the prepared whole cell proteins of H. pylori strain 51 (10 µg/mL and 50 µL per well diluted with coating buffer). Diluted sera (IgG 1:400, and IgA 1:100) were added to antigen-coated wells (50 µL per well). Anti-CagA IgG and IgA antibodies were evaluated by western blot using whole-cell lysates of H. pylori strain 51 (15). The western blot patterns were assigned to four categories on the basis of CagA (pattern I), urease without CagA (pattern II), other proteins except CagA and urease (pattern III), and no band (pattern IV) (Fig. 1).
Fig. 1

The immunoblot assay results were classified into four patterns on the basis of immunoreactive bands. Only pattern I, with reactivity against 120-kDa antigens and other H. pylori antigens, was considered to be a specific marker of H. pylori infection in this study. Panel A shows the Ponceau S‐stained nitrocellulose membrane onto which the marker proteins and separated H. pylori antigen were transferred.

The immunoblot assay results were classified into four patterns on the basis of immunoreactive bands. Only pattern I, with reactivity against 120-kDa antigens and other H. pylori antigens, was considered to be a specific marker of H. pylori infection in this study. Panel A shows the Ponceau S‐stained nitrocellulose membrane onto which the marker proteins and separated H. pylori antigen were transferred.

Statistical analysis

The statistical analyses were performed using IBM SPSS Statistics 21 (IBM, Chicago, IL, USA). We tested whether the antibody titer had significant correlations with the urease test results, antigen patterns, or age. We used bivariate correlation (Spearman’s rho), paired samples t-tests, and nonparametric tests to analyze the differences in the antibody titers between CagA-positive and-negative sera, among the three urease test grades, and in the three age groups. The numbers and sex ratios in the three age groups were different, so GLM regression analysis was used for correction. Post-hoc analysis using Scheffé’s method was applied when significant differences were detected among three groups. Statistically significant differences were accepted at P < 0.05.

Ethics statement

The study protocol was reviewed and approved by the institutional review board of GNUH (GNUHIRB-2015-08-020). Informed consent was exempted by the board.

RESULTS

Table 1 shows the number and sex distribution of the subjects according to age. There were no significant differences in the sex distributions among the age groups.

Results of the urease test and histopathological findings

The positivity rates for the urease test were 37.1% at 0–4 years, 38.0% at 5–9 years, and 39.9% at 10–15 years (P = 0.003). The degrees of chronic gastritis (P = 0.021), active gastritis (P = 0.064), and H. pylori infiltration (P < 0.001) increased with age (Table 1).

Anti-H. pylori IgG and IgA titers

The median titers for anti-H. pylori IgG were 732.5 IU/mL at 0–4 years, 689.0 IU/mL at 5–9 years, and 966.0 IU/mL at 10–15 years (P < 0.001). The median titers for anti-H. pylori IgA were 61.0 IU/mL at 0–4 years, 63.5 IU/mL at 5–9 years, and 75.0 IU/mL at 10–15 years (P < 0.001). The anti-H. pylori IgG titers were higher at 10–15 years than those at 1–5 years and 6–10 years (P = 0.006), but there was no significant difference in the anti-H. pylori IgA titers among the three age groups (P = 0.454).

Western blot patterns according to age groups

The proportions of IgG positivity according to the four western blot patterns (I–IV) were 36.0%, 47.7%, 5.5%, and 10.8%, respectively (P = 0.008). The proportions of IgA positivity according to the four patterns were 17.7%, 33.8%, 23.6%, and 25.0%, respectively (P = 0.221). The CagA-positivity rates were 26.5% at 0–4 years, 36.5% at 5–9 years, and 46.6% at 10–15 years for IgG (P = 0.036, Fig. 2), and 11.4% at 0–4 years, 18.6% at 5–9 years, and 23.3% at 10–15 years for IgA (P < 0.001) (Table 2). The western blot negative (no band) rates for IgG were 13.6%, 8.8%, and 12.6% at 0–4 years, 5–9 years, and 10–15 years, respectively. Post-hoc analysis using Scheffé’s method detected no differences in the proportions of the four western blot patterns among the three age groups for IgG (P = 0.094) and for IgA (P = 0.161).
Fig. 2

Proportions with the four western blot patterns according to age groups. The CagA-positivity rate was 26.5% at 0–4 years, 36.5% at 5–9 years, and 46.6% at 10–15 years for IgG (P = 0.036). Post-hoc analysis using Scheffé’s method detected no differences in the proportions with the four western blot pattern among the three age groups for IgG (P = 0.094).

Table 2

Proportions with the four western blot patterns according to age groups

Target proteinsNo. (%) of children by age group
0–4 yr5–9 yr10–15 yr
CagAIgG35 (26.5)100 (36.5)48 (46.6)
IgA15 (11.4)51 (18.6)24 (23.3)
UreaseIgG72 (54.5)133 (48.5)38 (36.9)
IgA39 (29.5)97 (35.4)36 (35.0)
Other proteinsIgG7 (5.3)17 (6.2)4 (3.9)
IgA52 (39.4)51 (18.6)17 (16.5)
No bandIgG18 (13.6)24 (8.8)13 (12.6)
IgA26 (19.7)75 (27.4)26 (25.2)
Proportions with the four western blot patterns according to age groups. The CagA-positivity rate was 26.5% at 0–4 years, 36.5% at 5–9 years, and 46.6% at 10–15 years for IgG (P = 0.036). Post-hoc analysis using Scheffé’s method detected no differences in the proportions with the four western blot pattern among the three age groups for IgG (P = 0.094).

Correlations between the urease test grade, degree of histopathological findings, western blot patterns, and antibody titers for IgG and IgA

The titers of anti-H. pylori IgG antibodies increased with the urease test grade (r = 0.527, P < 0.001), chronic gastritis (r = 0.613, P < 0.001), active gastritis (r = 0.545, P < 0.001), and the degree of H. pylori infiltration (r = 0.593, P < 0.001). The anti-H. pylori IgA titers also increased with the urease test grade (r = 0.450, P < 0.001), degree of chronic gastritis (r = 0.523, P < 0.001), active gastritis (r = 0.453, P < 0.001), and H. pylori infiltration (r = 0.480, P < 0.001). In the urease test, the anti-H. pylori IgG (Fig. 3) and IgA (Fig. 4) antibody titers were higher with grade I than the other grades (P < 0.001), regardless of age. According to the four western blot patterns, the anti-H. pylori IgG (Fig. 5) and IgA (Fig. 6) titers were higher with the CagA-positive pattern (P < 0.001), regardless of age.
Fig. 3

Anti-H. pylori IgG antibody titers according to age groups and the urease test grade. The anti-H. pylori IgG antibody titers were higher with grade I (positive within 6 hours) than the other grades (P < 0.001) in all age groups.

Fig. 4

Anti-H. pylori IgA antibody titers according to age groups and the urease test grade. The anti-H. pylori IgA antibody titers were higher with grade I (positive within 6 hours) than the other grades (P < 0.001) in all age groups.

Fig. 5

Anti-H. pylori IgG antibody titers according to the western blot patterns and age. The anti-H. pylori IgG antibody titers were higher with the CagA-positive pattern (P < 0.001) regardless of age.

Fig. 6

Anti-H. pylori IgA antibody titers according to the western blot patterns and age. The anti-H. pylori IgA antibody titers were higher with the CagA-positive pattern (P < 0.001) regardless of age.

Anti-H. pylori IgG antibody titers according to age groups and the urease test grade. The anti-H. pylori IgG antibody titers were higher with grade I (positive within 6 hours) than the other grades (P < 0.001) in all age groups. Anti-H. pylori IgA antibody titers according to age groups and the urease test grade. The anti-H. pylori IgA antibody titers were higher with grade I (positive within 6 hours) than the other grades (P < 0.001) in all age groups. Anti-H. pylori IgG antibody titers according to the western blot patterns and age. The anti-H. pylori IgG antibody titers were higher with the CagA-positive pattern (P < 0.001) regardless of age. Anti-H. pylori IgA antibody titers according to the western blot patterns and age. The anti-H. pylori IgA antibody titers were higher with the CagA-positive pattern (P < 0.001) regardless of age.

DISCUSSION

In the present study, we found that the presence of the CagA antigen was the major factor related to high levels of anti-H. pylori IgG and IgA antibodies, regardless of age. CagA is known to be an important virulence factor in H. pylori (14) and antibodies against CagA have been observed in gastritis, gastroduodenal ulcer, and gastric cancer patients (131617). In the early 2000s, 80%–100% of H. pylori strains possessed the cagA gene in East Asia (1819) and 94% were cagA-positive in H. pylori DNA extracts from 33 Korean children (20). In Japan, the CagA was the most reactive antigen recognized by all the H. pylori positive sera even from children under the age of 3 year (21). Therefore, the regional CagA antigens for serodiagnosis of H. pylori would be important, which could affect the rate of seropositivity (21). Thus, a positive test result for anti-CagA antibody was regarded as an H. pylori infection in Korean studies (1522). In the present study, the highest positivity rate for CagA was 46.6% among the 10–15 years group, although this CagA-positivity rate is lower than the seroprevalence (59.6%) of H. pylori infections in a recent study of the general population in Korea (23), as well as the seroprevalence rate (68.0% CagA-positive) in children aged 6–15 years using the same immunoblot analysis during 1998–1999 (17). Recent seroprevalence studies of H. pylori infection suggest that the decrease in the seroprevalence of H. pylori may be related to the improved socioeconomic status of Koreans (2324) Young children may have a different immune response to H. pylori, with preferences for specific antigens, as well as lower titers than adults (8). A lower sensitivity has been reported based on serological H. pylori tests in children compared with adults (25). Using commercial ELISA kits, false-negative results were found more often in children aged younger than 5 years (826). In our previous study, we showed that the Genedia IgG ELISA kit, which uses H. pylori antigen obtained from a Korean H. pylori strain, achieved a higher seropositivity rate than other ELISA kits (e.g., GAP IgG, HM-CAP, and Pyloriset EIA-G obtained from USA and Finland) (17). There are differences in the antigenicity of multiple H. pylori strains and even among different antigens in the same strain (9). In the present study, the median levels of anti-H. pylori IgG and IgA antibody also increased with age but the antibody titers were higher in the CagA-positive cases than those in the CagA-negative cases, even in children aged under 5 years. Age is strongly related to H. pylori infections (27). In the present study, the degree of chronic gastritis, active gastritis, and H. pylori infiltration and the positive urease test rate increased significantly with age. The CagA-positivity rate increased with age but not significantly. Previously, the grades of active and chronic inflammation, atrophy, lymphoid follicles, and H. pylori density were correlated with the IgG antibody levels in the antral mucosa (31128). The serum antibody response to H. pylori also depends on the severity of H. pylori-associated diseases (29). In the present study, the anti-H. pylori IgG and IgA antibody levels were correlated with the degree of chronic gastritis and H. pylori infiltration. The degrees of the histopathological findings and the anti-H. pylori IgG and IgA antibody titers were also correlated with the ages of the children. A positive urease test within 6 h was another factor that affected the anti-H. pylori IgG and IgA antibody levels regardless of age. Buffered urease tests require at least 1000 organisms to generate a positive reaction (30) and a higher degree of H. pylori infiltration is correlated with a faster positive reaction in the urease test (3132). Therefore, a rapid reaction in the urease test may be related to a high density of bacteria. In the present study, there was no significant correlation between the presence of anti-urease antibody, the titer of anti-H. pylori antibodies, and the urease test grade. The change in H. pylori strains from CagA-positive to CagA-negative in Korea should be considered when evaluating the seroepidemiology of H. pylori infections. The current study had some limitations as follows. We conducted the current study with a retrospective design. We simply analyzed the results of urease tests and histopathological findings in this study, and we did not evaluate the clinical histories of the children. In summary, we found that the anti-H. pylori IgG and IgA antibody titers were higher in the CagA-positive sera of children regardless of age, while higher IgG and IgA titers were observed with a higher degree of active gastritis and H. pylori infiltration, higher urease test grade, and greater age. In conclusion, the presence of CagA antigen is the main factor that affects the levels of anti-H. pylori IgG and IgA antibodies regardless of age. The ELISA test is a valuable diagnostic tool for diagnosing CagA-positive H. pylori infections in children. However, further studies are needed of CagA-negative strain infections and the levels of anti-H. pylori IgG and IgA antibodies.
  30 in total

Review 1.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Evaluation of a serological test for diagnosis of Helicobacter pylori infection in children.

Authors:  J Raymond; N Kalach; M Bergeret; J P Barbet; P H Benhamou; D Gendrel; C Dupont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

3.  Distribution of distinct vacA, cagA and iceA alleles in Helicobacter pylori in Hong Kong.

Authors:  B C Wong; Y Yin; D E Berg; H H Xia; J Z Zhang; W H Wang; W M Wong; X R Huang; V S Tang; S K Lam
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

4.  Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer.

Authors:  G A Rocha; A M Oliveira; D M Queiroz; A S Carvalho; A M Nogueira
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Comparison of serum antibody titers to Helicobacter pylori lipopolysaccharides, CagA, VacA and partially purified cellular extracts in a Japanese population.

Authors:  S Yokota; K Amano; N Fujii; T Yokochi
Journal:  FEMS Microbiol Lett       Date:  2000-04-15       Impact factor: 2.742

6.  Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.

Authors:  Lei Gao; Angelika Michel; Melanie N Weck; Volker Arndt; Michael Pawlita; Hermann Brenner
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

7.  Immunoglobulin G antibody against Helicobacter pylori: clinical implications of levels found in serum.

Authors:  Tseng-Shing Chen; Fen-Yau Li; Full-Young Chang; Shou-Dong Lee
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Seroprevalence of Helicobacter pylori Infection in Korean Health Personnel.

Authors:  Hyun Young Kim; Nayoung Kim; Seon Mie Kim; Ji-Hyun Seo; Eun-Ha Park; Dong Ho Lee
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

9.  Development of an ELISA for Quantitative Detection of Immunoglobulin G (IgG) and IgA Antibodies to Helicobacter pylori for Use in Korean Patients with H. pylori-Associated Diseases.

Authors:  Ji-Hyun Seo; Jin-Su Jun; Hee-Shang Youn; Jung Sook Yeom; Ji Sook Park; Chan-Hoo Park; Hyang-Ok Woo; Woo-Kon Lee; Myung-Je Cho; Kwang-Ho Rhee
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

10.  Correlation between positive rate and number of biopsy samples on urease test in childhood Helicobacter pylori infection.

Authors:  Ji-Hyun Seo; Ji Sook Park; Jung Sook Yeom; Jae-Young Lim; Chan-Hoo Park; Hyang-Ok Woo; Seung-Chul Baik; Woo-Kon Lee; Myung-Je Cho; Kwang-Ho Rhee; Hee-Shang Youn
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

View more
  6 in total

Review 1.  Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies.

Authors:  Kallirroi Kotilea; Nicolas Kalach; Matjaž Homan; Patrick Bontems
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

2.  Helicobacter pylori Antigens Inducing Early Immune Response in Infants.

Authors:  Ji Hyun Seo; Jong Hyuk Youn; Eun A Kim; Jin Su Jun; Ji Sook Park; Jung Sook Yeom; Jae Young Lim; Hyang Ok Woo; Hee Shang Youn; Gyung Hyuck Ko; Jin Sik Park; Seung Chul Baik; Woo Kon Lee; Myung Je Cho; Kwang Ho Rhee
Journal:  J Korean Med Sci       Date:  2017-07       Impact factor: 2.153

3.  Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings.

Authors:  Sang Pyo Lee; Sun Young Lee; Jeong Hwan Kim; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

4.  Changes in Seroprevalence of Helicobacter pylori Infection over 20 Years in Jinju, Korea, from Newborns to the Elderly.

Authors:  Ji Sook Park; Jin Su Jun; Eo Young Ryu; Jung Sook Yeom; Eun Sil Park; Ji Hyun Seo; Jae Young Lim; Chan Hoo Park; Hyang Ok Woo; Seung Chul Baik; Woo Kon Lee; Myung Je Cho; Kwang Ho Rhee; Hee Shang Youn
Journal:  J Korean Med Sci       Date:  2020-08-17       Impact factor: 2.153

Review 5.  Diagnosis of Helicobacter pylori Infection in Children and Adolescents in Korea.

Authors:  Ji-Hyun Seo; Ji-Sook Park; Kwang-Ho Rhee; Hee-Shang Youn
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-10-10

6.  Helicobacter pylori Infection and Autoimmune Thyroid Diseases: The Role of Virulent Strains.

Authors:  Natale Figura; Giovanni Di Cairano; Elena Moretti; Francesca Iacoponi; Annalisa Santucci; Giulia Bernardini; Stefano Gonnelli; Nicola Giordano; Antonio Ponzetto
Journal:  Antibiotics (Basel)       Date:  2019-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.